Article
Enhancing the Hygroscopic Stability of S‑Oxiracetam via
Pharmaceutical Cocrystals
Zi-Zhou Wang,† Jia-Mei Chen,*,‡ and Tong-Bu Lu*,†,‡
†MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Optoelectronic Materials and Technologies,
School of Chemistry and Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275, China
‡School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China
S
* Supporting Information
ABSTRACT: Four cocrystals of (S-ox)(ga) (1), (RS-ox)(ga)
(2), (S-ox)(pa) (3), and (RS-ox)(pa) (4) were prepared (S-ox
= S-oxiracetam, RS-ox = racemic oxiracetam, ga = gallic acid,
pa = 3,4-dihydroxybenzoic acid), and their structures were
determined by single X-ray diffraction. In 1/2, two ga
molecules link two S-ox/RS-ox molecules through intermolecular hydrogen bonds with a new R2 (9) synthon to form a
2
tetramer, the tetramers are further linked by intertetramer hydrogen bonds to generate a 2D sheet, and the adjacent 2D sheets
are connected by intersheet hydrogen bonds to form the 3D structure of 1/2. In 3/4, the ox molecules form a 1D helical chain
through intermolecular hydrogen bonds, and the helical chains are further linked by pa molecules through intermolecular
hydrogen bonds to form a 2D sheet. The results of hygroscopic stability experiments indicate that the hygroscopic stability of S-
ox is much enhanced after the formation of cocrystal 1.
ox)(ga), (S-ox)(pa), and (RS-ox)(pa) were synthesized (ga =
gallic acid, pa = 3,4-dihydroxybenzoic acid,14 see Scheme 1),
and their structures and hygroscopic stability were investigated.
INTRODUCTION
■
During the past decades, chiral drugs have been playing a
significant role in the pharmaceutical industry. By the year of
2002, chiral drugs with a single enantiomer dosage form share
39% of the world market,1 and the number is increasing year by
year. According to the guidance of development of new chiral
drugs,2 single enantiomers of new drugs are encouraged to be
developed, and a single enantiomer for a certain drug can be
marketed under a different name to its racemic mixture.
The nootropic drug oxiracetam (4-hydroxy-2-oxo-1-pyrroli-
dine acetamide, ox) was first synthesized by Smith Kline
Beecham Company in 1974.3 It is a racemic compound
comprised of S-ox and R-ox (see Scheme 1). The structure of
racemic oxiracetam (RS-ox) has been reported,4 while the
structure of its single enantiomer (S-ox or R-ox) has not been
reported so far. It has been reported that S-ox has better
performance than RS-ox in treatment of cognition dysfunction.5
However, we found that S-ox is heavily hygroscopic and
deliquesces to a liquid within 3 days at 87% RH and 25 °C,
while RS-ox is stable under the same conditions, and this is in
accordance with Wallach’s rule,6−12 which states that a racemic
crystal is expected to have a higher density than its chiral
counterpart, resulting in a more efficient packing and higher
overall stability.13 Recently, Jones et al.7 first found that the
hygroscopic stabilities of chiral and racemic cocrystals also
follow a trend of Wallach’s rule: that is, the racemic cocrystal
appears to be more stable than its chiral counterpart. However,
their results are based only on two sets of cocrystals, and it
needs more examples to confirm this assumption.
EXPERIMENTAL SECTION
■
General Remarks. S-ox and RS-ox were provided by Sichuan
Industrial Institute of Antibiotics. All of the coformers were purchased
from Aladdin Reagent Corporation. The solvents were commercially
available and used without further purification. Elemental analyses
were determined using an Elementar Vario EL elemental analyzer. The
IR spectra were recorded in the 4000 to 400 cm−1 region using KBr
pellets and a Thermo Scientific AVATAR330 FT-IR spectrometer.
Differential scanning calorimetry (DSC) was carried out on a Netzsch
STA 409PC instrument in N2 atmosphere. X-ray powder diffraction
(XRPD) patterns were obtained on a Bruker D8 Advance with Cu Kα
radiation (40 kV, 40 mA).
(S-ox)(ga), 1. A mixture of S-ox (0.158 g, 1 mmol) and ga (0.170 g,
1 mmol) was dissolved in 3 mL of methanol in a sealed flask, and
stirred at room temperature for 5 h. The resulting solution was
filtrated and evaporated slowly at room temperature. After about one
week, colorless prism-shaped crystals of 1 were isolated by filtration,
washed with diethyl ether, and dried under vacuum. Yield: 0.30 g, 91%.
Anal. Calcd for C13H16N2O8: C, 47.56; H, 4.91; N, 8.53. Found: C,
47.32; H, 5.12; N, 9.00%. IR data (KBr, cm−1) 3754 vs, 3195 s, 2980
m, 2375 w, 1686 s, 1659 s, 1604 m, 1495 w, 1451 m, 1396 m, 1349 w,
1285 s, 1248 m, 1077 w, 939 m, 863 w, 763 w, 706 w, 612 m, 457 w.
(RS-ox)(ga), 2. A mixture of RS-ox (0.158 g, 1 mmol) and ga
(0.170 g, 1 mmol) was stirred in 10 mL of ethanol in a sealed flask for
24 h, and the solution was filtrated and evaporated slowly at room
temperature. After about 2 weeks, colorless prism-shaped crystals of 2
In order to enhance the hygroscopic stability of S-ox and to
see whether the stability of their chiral and racemic cocrystals
follows the Wallach’s rule, four cocrystals of (S-ox)(ga), (RS-
Received: June 2, 2012
Revised: July 24, 2012
Published: August 7, 2012
© 2012 American Chemical Society
4562
dx.doi.org/10.1021/cg300757k | Cryst. Growth Des. 2012, 12, 4562−4566